AI Interview Questions for Doctors

I see AI note drafting as documentation support, not clinical judgment. It can help organize observations, produce cleaner first drafts, and reduce administrative load, but it should never decide what happened in the encounter or what the plan should be. I would only use it in a workflow where the clinician reviews every line, confirms the facts, and corrects anything ambiguous or overstated. The standard is that the note must still reflect the physician's own assessment. If AI saves time while preserving accuracy and accountability, it is useful. If it introduces doubt about what was actually observed or decided, it is not worth the risk.

The major risks are hallucinated facts, overconfident recommendations, privacy failures, and workflow misuse. AI can sound medically plausible while being wrong in a way that is hard to notice if someone is rushing. There is also risk when clinicians rely on a tool outside its intended use, such as treating a summarization assistant like a diagnostic system. I would also worry about poor data handling or unclear accountability when protected health information is involved. In healthcare, a useful AI tool is one that reduces burden without obscuring who is responsible for the final clinical decision. If that line gets blurry, the system is unsafe.

I would explain it plainly: the AI may help with organization, summarization, or draft language, but it is not independently diagnosing the patient or making care decisions. The clinician remains responsible for the record, the interpretation, and the plan. That distinction matters because trust depends on clarity. People are often more comfortable with AI when they understand that it is assisting documentation or information synthesis rather than replacing clinical expertise. If I cannot explain the role of the tool clearly in one or two sentences, the workflow is probably not transparent enough for a clinical environment.

I think the best initial use cases are administrative or documentation-heavy tasks that are still easy to supervise, such as note drafting, after-visit summaries, inbox triage support, literature summarization, and templated patient education drafts. I am more cautious with anything that implies diagnosis, triage, or treatment recommendations unless the system is narrow, validated, and used within strong governance. The key test is whether the workflow is low enough risk and reviewable enough that human oversight remains real rather than symbolic. AI is most valuable in healthcare when it reduces friction around care delivery without pretending to replace clinical reasoning.

I would check it against the source material in layers. First, I confirm the basic facts: patient details, timeline, medications, test results, and relevant symptoms. Second, I review whether the summary overstates certainty or omits important negatives. Third, I look for subtle language errors that could change meaning, such as implying a confirmed diagnosis when the note only supports a differential. Finally, I check whether the summary fits the audience. A clinician-facing summary and a patient-facing summary should not use the same wording. The review is not just proofreading. It is verifying that the summary reflects the actual clinical picture faithfully.

I start with whether the tool is approved for the setting, what agreements are in place, and how data is stored, retained, and processed. If a workflow handles PHI, I need clarity on access controls, retention, jurisdiction, and whether the system is being used in a way that aligns with organizational policy and legal obligations. I also prefer minimizing exposure by limiting the data shared to what is necessary for the task. In clinical settings, privacy is not a side issue to solve later. It is a gating requirement. If the vendor or workflow cannot explain how patient data is protected, the tool does not belong in the process.

I would use AI to accelerate synthesis, not to replace reading. It can summarize trial designs, highlight endpoints, and compare papers quickly, which is useful when screening a lot of material. But I would still review the original paper for methods, limitations, population fit, and whether the summary missed nuance. AI is especially risky when it compresses uncertainty or turns weak evidence into strong-sounding conclusions. My standard is that the summary should help me decide what to read and remember, not decide what I believe without checking the source. It is a starting point for judgment, not the substitute for it.

I would start with a narrow, low-risk use case that addresses a real pain point, usually documentation burden. Then I would define the workflow clearly: what the tool does, what it does not do, how review works, and how errors will be reported. I would also show examples of both helpful output and failure modes so the team learns realistic trust. Skeptical clinicians are often reacting to hype, not to thoughtful workflow design. The right way to introduce AI is to make it optional at first, gather feedback from real usage, and prove that it helps without changing the standard of care or obscuring accountability.

I would track time spent on documentation, clinician satisfaction, correction rate, note completion lag, and whether the tool changes after-hours charting burden. I would also track safety-oriented signals such as error categories, missing fields, and any cases where the draft created confusion or needed major rewrite. A tool that saves thirty seconds but introduces low-grade distrust can still fail. The best outcome is not just faster notes. It is lower burden with stable or improved documentation quality. If the clinicians are spending less time typing but more time correcting subtle inaccuracies, the apparent efficiency gain is misleading.

Human-in-the-loop only works if the human review is meaningful. That means the clinician has enough context, time, and authority to catch errors before the output becomes part of care. A checkbox review is not enough. The interface should make uncertainty visible, show the source material, and support correction easily. I also think the tool should be designed around the actual clinical decision boundary. If the clinician is expected to own the outcome, the workflow should make it easy to inspect, challenge, and override the AI. In medicine, human oversight is not decorative. It is part of the safety mechanism.

A healthcare organization should avoid AI when the use case is high stakes, poorly validated, hard to supervise, or impossible to audit. That includes workflows where incorrect output could directly shape treatment without a real review step, or where the team cannot explain how the tool handles data or uncertainty. It should also be avoided when the workflow is already functioning well and AI is being added only because it seems innovative. In healthcare, restraint is part of responsible adoption. Not every tedious process should be automated, especially if the automation makes failure modes harder to see or assign responsibility for.

The right mindset is cautious usefulness. AI can reduce administrative friction and improve information handling, but it should be treated like a capable assistant whose work must still be checked. Clinicians should be curious enough to learn where it helps and disciplined enough to reject it where it adds risk. That means testing workflows, understanding limitations, and keeping the patient's welfare at the center of the decision. The strongest clinicians will not be the ones who refuse every tool or trust every tool. They will be the ones who know where assistance improves care processes and where human judgment must remain fully in control.